Stemline Therapeutics (STML) Analysts See $-0.50 EPS; Shorts at Trico Bancshares (TCBK) Lowered By 3.06%

July 17, 2017 - By Louis Casey

Trico Bancshares (NASDAQ:TCBK) had a decrease of 3.06% in short interest. TCBK’s SI was 266,500 shares in July as released by FINRA. Its down 3.06% from 274,900 shares previously. With 63,000 avg volume, 4 days are for Trico Bancshares (NASDAQ:TCBK)’s short sellers to cover TCBK’s short positions. The SI to Trico Bancshares’s float is 1.41%. About 38,653 shares traded. TriCo Bancshares (NASDAQ:TCBK) has risen 30.78% since July 17, 2016 and is uptrending. It has outperformed by 14.08% the S&P500.

Analysts expect Stemline Therapeutics Inc (NASDAQ:STML) to report $-0.50 EPS on August, 3.They anticipate $0.02 EPS change or 3.85% from last quarter’s $-0.52 EPS. After having $-0.67 EPS previously, Stemline Therapeutics Inc’s analysts see -25.37% EPS growth. About 157,097 shares traded. Stemline Therapeutics Inc (NASDAQ:STML) has risen 52.65% since July 17, 2016 and is uptrending. It has outperformed by 35.95% the S&P500.

Among 3 analysts covering TriCo Bancshares (NASDAQ:TCBK), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. TriCo Bancshares had 3 analyst reports since January 29, 2016 according to SRatingsIntel. On Friday, July 29 the stock rating was downgraded by Keefe Bruyette & Woods to “Market Perform”.

Investors sentiment decreased to 0.96 in Q4 2016. Its down 0.38, from 1.34 in 2016Q3. It dropped, as 10 investors sold TriCo Bancshares shares while 41 reduced holdings. 11 funds opened positions while 38 raised stakes. 15.06 million shares or 0.06% less from 15.07 million shares in 2016Q3 were reported. Lsv Asset Mgmt has 393,808 shares for 0.02% of their portfolio. Rhumbline Advisers reported 23,902 shares. Symphony Asset Management Lc reported 12,911 shares. Comml Bank Of Ny Mellon Corporation stated it has 197,582 shares. Jpmorgan Chase & stated it has 0% in TriCo Bancshares (NASDAQ:TCBK). National Bank & Trust Of America Corporation De, a North Carolina-based fund reported 97,363 shares. Vanguard Incorporated reported 0% of its portfolio in TriCo Bancshares (NASDAQ:TCBK). Susquehanna Intl Grp Ltd Liability Partnership holds 45,560 shares. Pub Employees Retirement Association Of Colorado stated it has 11,800 shares or 0% of all its holdings. Blackrock Grp Inc Ltd accumulated 0% or 19,704 shares. Howe Rusling reported 0% of its portfolio in TriCo Bancshares (NASDAQ:TCBK). Bnp Paribas Arbitrage Sa reported 1,049 shares. Geode Limited Liability Company reported 0% stake. Ubs Asset Mgmt Americas Inc has invested 0% in TriCo Bancshares (NASDAQ:TCBK). Ameriprise Fin invested in 63,400 shares.

TriCo Bancshares is a bank holding company. The company has market cap of $798.75 million. The Company’s principal subsidiary is Tri Counties Bank, a California-chartered commercial bank . It has a 17.6 P/E ratio. The Bank offers banking services to retail clients and small to medium-sized businesses through 68 branch offices in Northern and Central California.

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on discovering, acquiring, developing and commercializing oncology therapeutics. The company has market cap of $279.10 million. The Firm is developing approximately three clinical stage product candidates, including SL-401, SL-701 and SL-801. It currently has negative earnings. SL-401 is a targeted therapy directed to the interleukin-3 receptor (CD123), present on a range of hematologic cancers.

Among 4 analysts covering Stemline Therapeutics Inc (NASDAQ:STML), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Stemline Therapeutics Inc had 7 analyst reports since November 10, 2015 according to SRatingsIntel. The rating was maintained by Cowen & Co with “Buy” on Friday, June 23. The stock of Stemline Therapeutics Inc (NASDAQ:STML) has “Buy” rating given on Monday, June 26 by H.C. Wainwright. The stock of Stemline Therapeutics Inc (NASDAQ:STML) has “Buy” rating given on Wednesday, June 14 by Cowen & Co. The rating was maintained by Wedbush with “Outperform” on Monday, February 6. As per Monday, June 26, the company rating was maintained by Jefferies.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.